Through presentations, roundtable discussions and networking, attendees of this meeting will compare the pros and cons of single-gene tests and whole genome, whole exome sequencing and examine techniques for identifying a variant as pathological. In addition to strategies for interpreting clinical data and creating a genomic profile, ethical considerations around incidental findings and prenatal screening will be debated. Experts will also weigh in on implementing genetic screening into routine clinical practice. The faculty is comprised of researchers at the center of advancements in genetic testing from Duke University, Medical College of Wisconsin, Children's Hospital of Philadeliphia, Children's Mercy Hospital, Partner's Canter for Personalized Genetic Medicine and UCLA School of Medicine.
The Inherited Disease Diagnostics Meeting will take place at the 2014 Next Generation Dx Summit, alongside a collection of eleven courses and ten conference programs covering the areas of point-of-care;
Full program details can be found at http://www.nextgenerationdx.com/
For a preview of the event, researchers are invited to listen to faculty-recorded podcasts at http://www.nextgenerationdx.com/
About Cambridge Healthtech Institute
Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, and Cambridge Healthtech Media Group.
Cambridge Healthtech Institute